Acta haematologica
Chronic Graft-Versus-Host Disease: A Review of Current Treatments Beyond Second-Line and Emerging Therapies.
Aseel Saadeh, Dayana Jibrin, Michael Haddadin
Published: 202610.1159/000550265
Abstract
BACKGROUND: Chronic graft-versus-host disease (cGVHD) remains a major cause of late morbidity and non-relapse mortality following allogeneic hematopoietic cell transplantation. Early identification and intervention are critical to improving outcomes.…
Preview only. Read the full abstract at the source